All raw data files are available from the ENA database (accession number(s) PRJEB35296 and PRJEB38743.

Introduction {#sec001}
============

Shiga toxin-producing *Escherichia coli* (STEC) are zoonotic pathogens, occurring as abundant commensals among ruminants while occasionally causing gastrointestinal disease in humans. STEC infections can lead to the rare, but severe, hemolytic uraemic syndrome (HUS), with children and the elderly being most at risk \[[@pone.0232305.ref001]\]. HUS can be fatal or lead to long-term sequelae with reduced kidney function or less commonly gastrointestinal or cognitive disabilities \[[@pone.0232305.ref002]\]. Though STEC constitute a genetically diverse group and all STEC should be considered potential agents of severe human disease \[[@pone.0232305.ref003]\], certain lineages appear to pose a far higher risk of causing HUS compared to other STEC. These STEC are referred to as HUSEC, i.e. *E*. *coli* previously associated with HUS \[[@pone.0232305.ref004]\]. In addition to the characteristics of the infecting STEC strain, the risk of developing HUS for a given patient is likely to be affected by host factors such as age and immunological status and possibly other factors like inoculum size and route of infection. Nonetheless, the identification of HUSEC strains is valuable for prioritizing interventions to reduce the exposure of humans to the most dangerous forms of STEC and to predict the progression of cases of illness.

STEC carry genes encoding Shiga toxins (Stx), considered to be their primary virulence factor. Stx genes are encoded by lambdoid bacteriophages that are maintained in a lysogenic stage in the bacterial chromosome \[[@pone.0232305.ref005]\]. Two types of Shiga toxins are known, Stx1 and Stx2, both of which are grouped into several subtypes. The presence of genes encoding a toxin variant referred to as Shiga toxin 2a (encoded by *stx*~2a~ genes) has been repeatedly shown to be a trait shared by the majority of HUSEC strains \[[@pone.0232305.ref004],[@pone.0232305.ref006],[@pone.0232305.ref007]\]. However, while the presence of *stx*~2a~ appears to be useful as a marker for the potential to cause HUS for strains infecting humans, the role of Shiga toxin in the ruminant reservoirs of STEC is poorly understood. Therefore, strains that cause severe disease in humans likely constitute a small and atypical subset of the overall STEC flora in ruminants. The prevalence and characteristics of major human pathogenic serotypes like O157:H7 that include known HUSEC have been extensively investigated in many countries over the last decades. Many other virulence-associated genes have been described and intimin (*eae*) is probably the principal adherence factor in human pathogenic STEC. The intimin gene is encoded on a pathogenicity island called the locus of enterocyte effacement (LEE), a genomic region encoding a system for attachment to the intestinal mucosa and translocation of effector proteins into host cells \[[@pone.0232305.ref003],[@pone.0232305.ref008]\]. LEE is common in pathogenic STEC, but not essential for causing severe disease \[[@pone.0232305.ref009]--[@pone.0232305.ref011]\]. LEE-negative (*eae*-negative) STEC strains have also been associated with severe disease such as HUS, and they probably possess alternative mechanisms for attachment, such as *aggR* described for STEC/EAEC O104:H4 \[[@pone.0232305.ref012]\] and *saa* as described for STEC O113:H21 \[[@pone.0232305.ref013]\]. Few if any studies have been performed with the aim of providing an unbiased and comprehensive view of STEC strains carrying *stx*~2a~ that occur in ruminant reservoirs. The aim of the present study was 1) to investigate the presence of *stx*~2a~ genes in cattle samples collected in Norway and Sweden, 2) investigate the presence of *stx*~2~ variants in cattle using high throughput amplicon sequencing and 3) characterize recovered *stx*~2a~-positive *E*. *coli* and relate their phylogeny and virulence characteristics to known HUSEC.

Materials and methods {#sec002}
=====================

Development of a real-time PCR for *stx*~2a~ {#sec003}
--------------------------------------------

A hydrolysis probe based real-time PCR assay for the detection of *stx*~2a~ ([Table 1](#pone.0232305.t001){ref-type="table"}) with primers containing locked nucleic acids (Exiqon A/S, Vedbaek, Denmark) was developed by alignment of 94 sequences of *stx*~2~ representing all the recognised subtypes, 2a through 2g \[[@pone.0232305.ref014]\]. The novel assay was tested against a panel of *E*. *coli* strains obtained from the EU reference laboratory for *E*. *coli* (Istituto Superiore di Sanità, Rome, Italy) and from Statens Serum Institut (Copenhagen, Denmark) with known *stx*~1~ and *stx*~2~ subtypes. The assay was also tested in parallel with conventional PCR for *stx*~2~ subtyping according to the reference laboratory \[[@pone.0232305.ref015]\] on a panel of STEC strains to verify the performance of the method ([Table 2](#pone.0232305.t002){ref-type="table"}). PCR efficiency was assessed by analysing serial dilutions of DNA from the positive control EDL933 in the Swedish lab. DNA concentration was measured using Qubit QuantIT HS kit (Invitrogen, Carlsbad, CA).

10.1371/journal.pone.0232305.t001

###### Primers and hydrolysis probes used in this study for screening of Shiga toxin genes.

![](pone.0232305.t001){#pone.0232305.t001g}

  Designation   Sequence 5'-3' with modifications[\*](#t001fn001){ref-type="table-fn"}   Usage                                                                Reference
  ------------- ------------------------------------------------------------------------ -------------------------------------------------------------------- ---------------------------------------------------------
  stx-F         `TTTGTYACTGTSACAGCWGAAGCYTTACG`                                          *stx*~1~ and *stx*~2~ real-time PCR                                  \[[@pone.0232305.ref016]\]
  stx-R         `CCCCAGTTCARWGTRAGRTCMACRTC`                                                                                                                  
  stx1-probe    `CY5-CTGGATGATCTCAGTGGGCGTTCTTATGTAA-BHQ2`                                                                                                    
  stx2-probe    `FAM-TCGTCAGGCACTGTCTGAAACTGCTCC-BHQ1`                                                                                                        
  VT2a-QfLNA    `GGCGG+TTTT+ATT+TGCATTA+G`                                               *stx*~2a~ real-time PCR                                              This study
  VT2a-QrLNA    `CG+TC+AAC+CTT+CACTGT+A`                                                                                                                      
  VT2a-Qp       `ATTO550-CRCAATCCGCCGCCATTGCATTAACAGAA-BHQ2`                                                                                                  
  F4_ad         `TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGGCACTGTCTGAAACTGCTCCTGT`              *stx*~2~ amplicon sequencing[^a^](#t001fn003){ref-type="table-fn"}   Modified from Persson et al. \[[@pone.0232305.ref006]\]
  F4f_ad        `TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCGCTGTCTGAGGCATCTCCGCT`                                                                                     
  R1_ad         `GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATTAAACTGCACTTCAGCAAATCC`                                                                                  
  R1ef_ad       `GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTAAACTTCACCTGGGCAAAGCC`                                                                                    

\*Y = C or T, S = G or C, W = A or T, R = A or G, M = A or C

LNA, locked nucleic acid, as indicated by a preceding plus sign in the primer sequence.

^a^ *stx*~2~ specific sequences in bold and adapter sequences in italics.

10.1371/journal.pone.0232305.t002

###### Shiga toxin-producing *Escherichia coli* strains and other *E*. *coli* variants for exclusion and inclusion criteria using an *stx*~2a~-specific real-time PCR.

![](pone.0232305.t002){#pone.0232305.t002g}

                                                                                                                Real-time PCR   Conventional PCR \[[@pone.0232305.ref015]\]   
  ------------------------------------- ------------- ---------------------------- ---------------------------- --------------- --------------------------------------------- ---------------------------------------
  Strains tested in the Swedish lab.    O26           35989                        cattle                       \+              \+                                            *nd*
  O26                                   60409         cattle                       \+                           \+              *nd*                                          
  O26                                   56296         human                        \+                           \+              *nd*                                          
                                        O26           56299                        human                        \+              \+                                            *nd*
                                        O26           11929                        human                        \+              \+                                            *nd*
                                        O121          93404                        cattle                       \+              \+                                            *nd*
                                        O121          93671                        cattle                       \+              \+                                            *nd*
                                        O121          56304                        human                        \+              \+                                            *nd*
                                        O121          61726                        human                        \+              \+                                            *nd*
                                        O121          61734                        human                        \+              \+                                            *nd*
                                        O157          7351                         cattle                       \+              \+                                            *nd*
                                        O157          7353                         cattle                       \+              \+                                            *nd*
                                        O157          7881                         cattle                       \+              \+                                            *stx*~2c~
                                        SF-O157       73985                        human                        \+              \+                                            *nd*
                                        O103          61704                        human                        \+              \+                                            *nd*
                                        O103          6                            human                        \+              \+                                            *nd*
                                        O104:H4       34474                        human                        \+              \+                                            *nd*
                                        O157:H7       EDL933                       \[[@pone.0232305.ref014]\]   \+              \+                                            *stx*~1a~
                                        O121          77173                        QA                           \+              \+                                            *nd*
                                        O157          77180                        QA                           \+              \+                                            *nd*
                                        O157          77185                        QA                           \+              \+                                            *nd*
                                        O48:H21       81459                        QA                           \+              \+                                            *stx*~1a~
                                        O103          23866                        QA                           \+              \+                                            *nd*
                                        O26           77179                        QA                           \+              \+                                            *nd*
                                        O26           14684                        cattle                       \-              \-                                            *nd*
                                        O26           2733                         cattle                       \-              \-                                            *nd*
                                        O157          492                          cattle                       \-              \-                                            *stx*~2c~
                                        O157          55439                        cattle                       \-              \-                                            *stx*~2c~
                                        O157          52063                        cattle                       \-              \-                                            *stx*~2c~
                                        O103          61713                        human                        \-              \-                                            *nd*
                                        O157          CCUG 42744                   REF                          \-              \-                                            *stx*~1a~ and *stx*~2c~
                                        *E*. *coli*   ATCC 35218                   REF                          \-              \-                                            *nd*
                                        O174:H21      81460                        QA                           \-              \-                                            *stx*~2b~ and *stx*~2c~
                                        O118:H12      81462                        QA                           \-              \-                                            *stx*~2b~
                                        O73:H18       81463                        QA                           \-              \-                                            *stx*~2d~
                                        unknown       81464                        QA                           \-              \-                                            *stx*~2g~
                                        ONT:H19       81465                        QA                           \-              \-                                            *stx*~1d~
                                        unknown       81466                        QA                           \-              \-                                            *stx*~2f~
                                        O174:H8       81467                        QA                           \-              \-                                            *stx*~1c~ and *stx*~2b~
                                        O139:H1       81468                        QA                           \-              \-                                            *stx*~2e~
  Strains tested in the Norwegian lab   O113          51033                        minced meat                  \+              \+                                            *stx*~1a~ and *stx*~2dact~
  O157:H7                               EDL933        \[[@pone.0232305.ref014]\]   \+                           \+              *stx*~1a~                                     
  O48:H21                               94C           \[[@pone.0232305.ref014]\]   \+                           \+              *stx*~1c~                                     
                                        O146:H21      NVI_257                      QA                           \+              \+                                            \-
                                        O157:H7       NVI_856                      QA                           \+              \+                                            *stx*~2c~
                                        O26:H11       102--09817                   Human                        \+              \+                                            \-
                                        O103:H25      11060424                     Human                        \+              \+                                            \-
                                        O26:H11       1107--2514                   Human                        \+              \+                                            \-
                                        O26:H11       1107--2561                   Human                        \+              \+                                            \-
                                        O145:H28      11101865                     Human                        \+              \+                                            \-
                                        O145:H28      11111058                     Human                        \+              \+                                            \-
                                        O157:H7       NVI-5768                     QA                           \+              \+                                            *stx*~2c~
                                        O121:H19      NVI-6694                     QA                           \+              \+                                            \-
                                        O157:H7       NVI-8375                     QA                           \+              \+                                            \-
                                        O26:H11       NVI-9669                     QA                           \+              \+                                            \-
                                        O145:H25      2013-22-83-1-2               Sheep                        \+              \+                                            \-
                                        O121          NVI-9529                     QA                           \+              \+                                            \-
                                        O145          000816                       Human                        \+              \+                                            \-
                                        O26:H11       2007-60-10067                Sheep                        \+              \+                                            \-
                                        O26:H11       2007-60-10714                Sheep                        \+              \+                                            \-
                                        O26:H11       2007-60-11809                Sheep                        \+              \+                                            \-
                                        O174:H8       DG131/3                      \[[@pone.0232305.ref014]\]   \-              \-                                            *stx*~1c~ and *stx*~2b~
                                        O118:H12      EH250                        \[[@pone.0232305.ref014]\]   \-              \-                                            *stx*~2b~
                                        O174:H21      31                           \[[@pone.0232305.ref014]\]   \-              \-                                            *stx*~2b~ and *stx*~2c~
                                        O73:H18       C165-02                      \[[@pone.0232305.ref014]\]   \-              \-                                            *stx*~2d~
                                        O139:H1       S1191                        \[[@pone.0232305.ref014]\]   \-              \-                                            *stx*~2e~
                                        O128ac:H2     T4/97                        \[[@pone.0232305.ref014]\]   \-              \-                                            *stx*~2f~
                                        O2:H25        7v                           \[[@pone.0232305.ref014]\]   \-              \-                                            *stx*~2g~
                                        O171:H2       NVI-136                      QA                           \-              \-                                            *stx*~2b~ and *stx*~2c~ and *stx*~2d~
                                        O145:H34      NVI-298                      QA                           \-              \-                                            *stx*~2f~
                                        O139:H1       NVI-427                      QA                           \-              \-                                            *stx*~2e~
                                        O2:H25        NVI-937                      QA                           \-              \-                                            *stx*~2g~
                                        O22:H8        NVI-949                      QA                           \-              \-                                            *stx*~1c~ and *stx*~2b~
                                        O91:H21       NVI-967                      QA                           \-              \-                                            *stx*~2d~
                                        O128:H-       E120                         Sheep                        \-              \-                                            *stx*~1d~ and *stx*~2b~
                                        O146:H21      E382                         Human                        \-              \-                                            *stx*~1d~ and *stx*~2b~
                                        O166:H15      NVI-2134                     QA                           \-              \-                                            *stx*~2d~
                                        O113:H4       NVI-3748                     QA                           \-              \-                                            *stx*~1c~ and *stx*~2b~
                                        O146:H21      NVI-9954                     QA                           \-              \-                                            *stx*~2d~
                                        O157          2014-01-5652                 Cattle                       \-              \-                                            *stx*~2c~

QA, quality assurance test strains obtained from the European reference laboratory for *E*. *coli* (Istituto Superiore di Sanità, Rome, Italy) or Statens Serum Institut (Copenhagen, Denmark). REF, reference strain. nd, not done.

Samples {#sec004}
-------

As part of a nationwide prevalence survey of STEC in Swedish cattle, individual faecal and skin (ear) samples were collected at different slaughterhouses during 2011 to 2012. The total number of faecal and skin samples were 2041 and 418, respectively. Skin samples are likely to reflect bacteria previously shed by the individual animal as well as bacteria shed by other animals in the same group transferred via the environment or direct interaction e.g. grooming. They allow the efficient recovery of strains representative of a group of animals as they tend to be positive more often compared to individual faecal samples; the collection of ears for this purpose is easily standardized \[[@pone.0232305.ref017]\]. The number of samples collected at different slaughterhouses were determined to represent the geographical distribution of cattle in Sweden. In Norway, pooled faecal samples were collected through a nationwide survey sampling dairy herds with more than 50 cows in 2014 \[[@pone.0232305.ref018]\]. From each herd, faecal material was collected from ten different places, and were to include all present age groups. In total, samples were retrieved from 179 dairy herds.

Sample preparation and isolation of *stx*~2a~-positive *E*. *coli* {#sec005}
------------------------------------------------------------------

All samples were enriched in buffered peptone water at 37°C for 18--20 hours. After enrichment, DNA was extracted directly from the enrichment broths using QIAamp DNA Stool Mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The extracted DNA was used for testing for the presence of Shiga toxin genes; *stx*~1~, *stx*~2~ and *stx*~2a~ as described below. Isolation of *stx*~2a~-positive *E*. *coli* was attempted from all *stx*~2a~-positive samples, comprising plating onto different agar plates (i.e. MacConkey agar, Sorbitol MacConkey agar and/or CHROMagar^™^ O157) and incubation at 37°C overnight. Colonies with presumptive *E*. *coli* morphology were selected for further testing for presence of *stx*~2a~ and DNA was extracted from colony material by boiling and tested by the *stx*~2a~ real-time PCR. Presumptive *stx*~2a~-positive *E*. *coli* were confirmed as *E*. *coli* using MALDI-TOF-MS (Bruker, Bremen, Germany) and characterized by WGS as described below. Extracted DNA from a subset of cattle skin (ear) samples were subjected to high-throughput amplicon sequencing of *stx*~2~ genes.

Real-time PCR detection of *stx* genes {#sec006}
--------------------------------------

DNA extracts from all the enriched samples were subjected to screening by real-time PCR for the detection of *stx*~1~ and *stx*~2~ as described by Perelle *et al*. 2004 \[[@pone.0232305.ref016]\] and ISO/TS 13136:2012 \[[@pone.0232305.ref019]\] as well as for *stx*~2a~ by the novel real-time PCR assay ([Table 1](#pone.0232305.t001){ref-type="table"}). The PCR analyses were performed slightly differently in Sweden versus in Norway; In the Swedish lab, PCR was performed in 15 μL PCR-reaction volumes containing 333 nM of each primer, 100 nM of probe, 2 μL template DNA and PerfeCTa qPCR Toughmix with Low ROX (Quantabio, Beverly, MA). PCR was conducted with an ABI 7500 Fast thermocycler (Life Technologies, Carlsbad, CA) using the following thermal profile: 95°C for 3 minutes followed by 45 cycles of 95°C for 3 seconds and 60°C for 30 seconds at which fluorescence was measured. Samples were regarded as positive if they resulted in a Ct-value \<45. In the Norwegian lab, PCR was performed in 20 μL PCR-reaction volumes containing 333 nM of each primer, 100 nM of probe, 5 μL template DNA and 10 μL Brilliant III Ultra-Fast QPCR Master Mix (Agilent Technologies, Santa Clara, CA). PCR was conducted with a Stratagene Mx3005P (Agilent technologies) using the following thermal profile: 95°C for 3 minutes followed by 45 cycles of 95°C for 3 seconds and 60°C for 30 seconds at which fluorescence was measured. Samples were regarded as positive if they resulted in a Ct-value \<45.

High-throughput amplicon sequencing of *stx*~2~ genes from skin samples {#sec007}
-----------------------------------------------------------------------

To further estimate the prevalence of *stx*~2~ variants and combinations of variants, the sequencing protocol developed by Persson and co-workers \[[@pone.0232305.ref006],[@pone.0232305.ref014]\] was adapted to the deep amplicon sequencing protocol provided by Illumina \[[@pone.0232305.ref020]\]. The modified primers are shown in [Table 1](#pone.0232305.t001){ref-type="table"}. This assay was applied to DNA extracted from enrichment broths of a subset of 48 *stx*~2~ PCR-positive Swedish cattle skin (ear) samples. Amplicons generated using the modified primers were barcoded using Nextera XT index kit (Illumina, San Diego, CA). An Illumina MiSeq instrument was used for sequencing 250 base pairs in both directions. Primer sequences were removed and reads were quality trimmed using Trimmomatic 0.32 \[[@pone.0232305.ref021]\]. Any read pair with less than 200 bp of high quality sequence from each direction was discarded. Read pairs were mapped against 89 known *stx*~2~ variants \[[@pone.0232305.ref014]\], and the closest match for each read pair was determined. Samples were discarded if less than 100 read pairs were consistent with *stx*~2~, and any sequence variant supported by \<5% of the total reads for a given sample was ignored to remove spurious variants generated by sequencing errors. With the minimum accepted length of 2 × 200 bp, all known variants could be unambiguously classified as either *stx*~2~ subtype a, b, c, d, e, f or g with the exception of the sequence variants AF500189 (*stx*~2d~, could not be distinguished from certain *stx*~2c~) and M59432 (*stx*~2c~, could not be distinguished from certain *stx*~2a~) which occurred in zero and one sample respectively.

Statistical analysis {#sec008}
--------------------

Shiga toxin gene prevalence with 95% confidence intervals were calculated by the exact binomial test using R version 3.6.2 for Windows \[[@pone.0232305.ref022]\].

Whole genome sequencing of *stx*~2a~-positive *E*. *coli* isolates {#sec009}
------------------------------------------------------------------

DNA was extracted from *stx*~2a~-positive *E*. *coli* isolates with QIAmp DNA mini kit or using an EZ1 Biorobot with the DNA Tissue kit (Qiagen, Hilden, Germany). The Nextera XT Kit (Illumina, San Diego, CA) was used to prepare libraries. The Swedish isolates were sequenced on a MiSeq (Illumina, San Diego, CA) as paired-end 2×250 base pair reads and the Norwegian isolates were sequenced on a HiSeq 2500 instrument using rapid mode generating paired-end reads from each isolate in two lanes i.e. 2×2×250 base pair reads. All isolates were sequenced to \>30 × depth. Quality control was performed using FastQC and sequence data was uploaded to the European Nucleotide Archive under project numbers PRJEB35296 and PRJEB38743 for the Swedish and Norwegian data respectively. Reads were trimmed and draft assemblies were generated using SPAdes 3.5.0.

Genomic characterization of *stx*~2a~-positive *E*. *coli* isolates {#sec010}
-------------------------------------------------------------------

The phylogroup of the *stx*~2a~-positive *E*. *coli* isolates was determined by *in silico* implementation of the PCR system of Clermont et al. \[[@pone.0232305.ref023]\] on assembled genomes. Multilocus sequence typing (MLST) \[[@pone.0232305.ref024]\], *in silico* serotyping \[[@pone.0232305.ref025]\] and virulence gene detection \[[@pone.0232305.ref026]\] was performed using Centre for Genomic Epidemiology web services \[[@pone.0232305.ref027]\]. Clustering of MLST data was performed using the minimum spanning tree algorithm in Bionumerics 7.6 (Applied Maths NV, Sint-Martens-Latem, Belgium), with each locus as an equivalent categorical variable. Multiple correspondence analysis was performed on virulence gene presence/absence data in R 3.5.0 \[[@pone.0232305.ref022]\] using the FactoMineR library.

Results {#sec011}
=======

Development of a real-time PCR for *stx*~2a~ {#sec012}
--------------------------------------------

The specificity of the novel PCR assay was confirmed at both laboratories by analyzing clinical and reference strains encoding *stx*~1~ and/or *stx*~2~. All 45 *stx*~2a~-positive strains and none of the 35 *stx*~2a~-negative strains were identified as *stx*~2a~-positive by the real-time PCR ([Table 2](#pone.0232305.t002){ref-type="table"}). The PCR efficiency was calculated to be 75% based on the standard curve from serial dilutions of DNA from EDL933.

Detection of *stx* gene variants in cattle samples {#sec013}
--------------------------------------------------

[Table 3](#pone.0232305.t003){ref-type="table"} presents the prevalence, with their corresponding 95% confidence intervals, of the various *stx* genes in samples from the two cattle surveys in Sweden and Norway, respectively. In short, for skin (ear) samples taken in the Swedish survey the prevalence was 64.1%, 78.7% and 1.6% for *stx*~1~, *stx*~2~ and *stx*~2a~, respectively. The corresponding results for the faecal samples in Sweden were 37.2% for *stx*~1~, 52.9% for *stx*~2~ and 5.0% for *stx*~2a~. The herd prevalence detected from the pooled faecal samples in Norway were 79.3%, 93.9% and 16.8% for *stx*~1~, *stx*~2~ and *stx*~2a~, respectively.

10.1371/journal.pone.0232305.t003

###### Prevalence of Shiga toxin genes (with 95% CI) in Swedish dairy cattle and Norwegian dairy herds using different sampling procedures.

![](pone.0232305.t003){#pone.0232305.t003g}

  Sample          Total   *stx*~1~   *stx*~2~            *stx*~2a~                             
  --------------- ------- ---------- ------------------- ----------- ------------------- ----- -------------------
  Sweden                                                                                       
  skin            418     268        64.1 (59.3--68.7)   329         78.7 (74.5--82.5)   7     1.6 (0.7--3.4)
  faecal          2041    760        37.2 (35.1--39.4)   1081        52.9 (50.8--55.1)   103   5.0 (4.1--6.1)
  Norway                                                                                       
  pooled faecal   179     142        79.3 (73.0--85.0)   168         93.9 (89.3--96.9)   30    16.8 (11.6--23.1)

Amplicon sequencing of a subset of Swedish *stx*~2~ PCR-positive skin broth samples produced high-quality output for 31 of 48 samples, revealing a high number of samples being positive for *stx*~2a~ (71.0%) and *stx*~2d~ (48.4%), with a lower proportion of samples positive for *stx*~2c~ (9.7%), *stx*~2g~ (9.7%), and *stx*~2b~ (6.5%) ([Fig 1A](#pone.0232305.g001){ref-type="fig"}). Most samples were positive for only a single *stx*~2~ variant, but several were positive for two or three different variants, most commonly *stx*~2a~ together with *stx*~2d~ ([Fig 1B](#pone.0232305.g001){ref-type="fig"}). Only four out of the 22 samples in which *stx*~2a~ was identified by amplicon sequencing were positive for *stx*~2a~ when tested by real-time PCR.

![Prevalence of Shiga toxin 2 variants in 31 *stx*~2~-positive skin samples from Swedish cattle evaluated by amplicon sequencing.\
The figure shows (A) the prevalence, with 95% confidence intervals, of each *stx*~2~ variant and (B) combinations of different toxin variants found in individual samples.](pone.0232305.g001){#pone.0232305.g001}

Genomic characterization of *stx*~2a~-positive *E*. *coli* isolates {#sec014}
-------------------------------------------------------------------

In total, 40 *stx*~2a~-positive *E*. *coli* isolates were retrieved from the Swedish (n = 25) and the Norwegian (n = 15) samples by plating the enriched samples onto selective agar plates and selecting one isolates per positive sample. One isolate was determined not to be *stx*~2a~-positive after genome analysis and excluded from further analysis, bringing the total number of included isolates to 39. Characteristics of the *stx*~2a~-positive *E*. *coli* isolates are summarized in [Fig 2](#pone.0232305.g002){ref-type="fig"} and [S1 Table](#pone.0232305.s001){ref-type="supplementary-material"}. Most of the isolates belonged to phylogroup B1 (n = 27), but A (n = 8) and B2 (n = 3) were also represented. One isolate could not be assigned to a phylogroup as it presented an undefined profile (+/-/+/+). A total of 19 MLST profiles were identified, of which 11 profiles formed three clonal complexes (CC) centered around ST-10 (phylogroup A, CC10, 9 isolates), ST-223 (phylogroup B1, CC155, 7 isolates) and ST-718 (phylogroup B1, 10 isolates from different predefined and undefined CC's). These three CC's were recovered from both Swedish and Norwegian cattle ([Fig 3](#pone.0232305.g003){ref-type="fig"}). Isolates were assigned to a CC if they differed from one another by a maximum of three loci. *In silico* serotyping revealed substantial diversity but was generally in agreement with MLST and phylogroup divisions ([Fig 2](#pone.0232305.g002){ref-type="fig"}). Virulence gene detection revealed five isolates to be "classical" LEE-positive STEC with intimin (*eae*), *tir*, *tccP* and a repertoire of non-LEE encoded effector genes. These isolates were O121:H19 (ST-655), O26:H11 (ST-21), O84:H2 (ST-306, two isolates) and O101:H33 (ST-330). Notably, 36 of the 39 isolates were positive for haemolysin genes (*ehxA*). Multiple correspondence analysis supported the presence of a distinctive group of LEE-positive isolates and a second group of STEC/ETEC (enterotoxigenic *E*. *coli*) hybrids with heat-stable enterotoxin 1 (*sta*~1~) but lacking *lpfA* and *espP* among other traits ([Fig 4](#pone.0232305.g004){ref-type="fig"}). The latter group corresponded to the previously mentioned CC10 clonal complex. A single isolate in this complex (O101:H33 ST-330) was intermediate in being both LEE-positive and an STEC/ETEC hybrid.

![Virulence gene profiles, sequence types, phylogroups and serotypes of 39 *stx*~2a~-positive *E*. *coli* isolates from cattle in Sweden and Norway.\
Two outbreak strains of EHEC (O157:H7 TW14359 and O121:H19 16--9255) are included as references. U; undetermined phylogroup or sequence type. ONT; antigen non-typable. O2 not distinguishable from O50. O101 not distinguishable from O162. O153 not distinguishable from O178.](pone.0232305.g002){#pone.0232305.g002}

![Minimum spanning tree of sequence types among *stx*~2a~-positive *E*. *coli* from cattle.\
All three major clonal complexes comprise isolates of both Swedish (blue) and Norwegian (red) origin. A difference in only one SNP is displayed by a thick line whereas a difference in two SNP's is displayed by a thin line.](pone.0232305.g003){#pone.0232305.g003}

![Multiple correspondence analysis biplots of the virulence genes of *stx*~2a~-positive *E*. *coli* from Norwegian and Swedish cattle.\
Association between virulence genes is estimated based on co-occurence in isolates (A), and association between isolates is estimated based on the genes they possess or lack (B).](pone.0232305.g004){#pone.0232305.g004}

Discussion {#sec015}
==========

Prevalence of *stx*~2~ and *stx*~2a~ in cattle {#sec016}
----------------------------------------------

Shiga toxin-producing *E*. *coli* are generally considered a normal part of the healthy ruminant intestinal flora, so the high prevalence of both *stx*~1~ and *stx*~2~ genes observed among cattle in the present study is not surprising. As some STEC seem to be more associated with severe human infection than others, the general detection of *stx* genes without any knowledge of the subtypes present is not well suited for detecting severe human pathogens. The *stx* genes are encoded in prophage genomes, and free phage particles might increase the load of PCR-detectable *stx* genes in environments where *stx*-carrying bacteria are present. Both shedding and colonization status for ruminants with STEC can be expected to be periodic or transient; the presence of potential pathogens on the herd level can therefore be more relevant compared to the prevalence in individual animals.

In the Swedish survey, the skin (ear) samples resulted in higher prevalence's than the corresponding faecal samples. This is in concordance with previous results from Sweden \[[@pone.0232305.ref017]\], and indicate that skin (ear) samples represents the prevalence in an animal herd or group and not individual animals. The Norwegian survey analyzed pooled faecal samples collected from dairy herds, giving herd prevalence and not individual which is probably the reason these resulted in the highest *stx* prevalence. Due to the differences in sampling and study design, the *stx* prevalence in the two countries cannot be compared directly. This was not the purpose of this study.

In recent years, studies have shown that STEC strains carrying *stx*~2~ are more pathogenic than those carrying only *stx*~1~, while STEC strains with the *stx*~2a~ subtype are most frequently associated with severe STEC disease manifestation; HUS \[[@pone.0232305.ref004],[@pone.0232305.ref006],[@pone.0232305.ref007]\]. The association between *stx*~2a~ and HUS made this subtype a particular focus of the presented study. As more STEC strains have been investigated by whole genome sequencing over the years it has been shown that there are sequence diversity within the *stx*~2a~ subtype, with some variants being highly similar to sequence variants of the *stx*~2c~ subtype \[[@pone.0232305.ref014]\]. In the present study, a novel real-time PCR assay was developed to specifically detect *stx*~2a~ genes. This PCR was employed for primary screening of samples in order to identify samples for attempting isolation of *stx*~2a~-positive *E*. *coli* isolates from the two countries for further characterization. As specificity was the primary concern in the development of this PCR, the sensitivity is likely to be suboptimal and the PCR level prevalence of *stx*~2a~ reported for the different sample types should be interpreted with caution. The poor sensitivity was a necessary trade-off to produce a sufficiently specific assay for identifying *stx*~*2a*~-positive samples due to the high sequence similarity of *stx*~*2a*~ compared to other *stx*~*2*~ subtypes. The real-time PCR described here has successfully been employed in two different laboratories using different PCR reagents and platforms which indicates that the method is robust and can easily be used in different laboratories. As the real-time PCR has not been tested on spiked samples with known levels of *stx*~2a~-positive STEC we do not know how the Ct values relates to number of cells. We are, however, aware that a Ct-value of 45 might be a false positive. In the case of *stx*~2a~-positive STEC, we consider it more important to avoid false negative samples than having a few false positive samples.

A community profiling approach based on amplicon sequencing of partial *stx*~2~ genes was used on a subset of the *stx*~2~ PCR-positive samples. This revealed *stx*~2a~ and *stx*~2d~ to be the most common types of *stx*~2~ among Swedish cattle samples, but also the presence of several other variants and combinations of variants. With these results in mind, identifying all potential STEC in a sample, especially an environmental or primary production sample, one would need to retrieve and test several isolates. This is in line with recommendations in ISO/TS-13136:2012 \[[@pone.0232305.ref019]\]. It is also reasonable to believe that one or more *stx*~1~-subtypes, in addition to several *stx*~2~-subtypes, could be present in a sample as well as different strains with the same *stx*~1~- or *stx*~2~-subtype, e.g. *stx*~2a~ could be present in two different genomic backbones in the same sample. However, this was beyond the scope of this study. The approach of using amplicon sequencing described in this study is a powerful tool for detecting all known *stx*~2~ variants in a sample, only limited by the inclusivity of the standard *stx*~2~ sequencing primers. A comparison between the real-time PCR and amplicon sequencing results revealed that only four out of 22 samples positive for *stx*~2a~ by amplicon sequencing were also positive for the same subtype by PCR. Although the limit of detection for the PCR was low when evaluated using purified DNA from a defined strain this might not be the case for mixed samples where other subtypes of *stx*~2~ may interfere with the amplification. However, there might also be an actual difference in the analytical sensitivity between the two methods. The real-time PCR was primarily used in this study as a screening tool in order to retrieve *stx*~2a~-positive *E*. *coli* and therefore the discrepant results were not further investigated.

Characteristics and public health relevance of LEE-positive STEC isolates {#sec017}
-------------------------------------------------------------------------

Most STEC associated with HUS reported in the literature to date have carried *stx*~2a~ genes in combination with the locus of enterocyte attachment and effacement (LEE) \[[@pone.0232305.ref028]\]. In the present study, only one LEE-positive isolate was detected from the Swedish samples; an O121:H19. STEC O121:H19 is a well-known cause of severe outbreaks and sporadic infections, and is a known HUSEC \[[@pone.0232305.ref004],[@pone.0232305.ref029]\]. From the Norwegian samples one LEE-positive STEC of serotype O26:H11 was detected. This serotype is known to carry different variants of *stx* genes or to be *stx*-negative when isolated from ruminants, and *stx*~2a~-positive strains of O26:H11 have caused several cases of HUS in Norway \[[@pone.0232305.ref030]\] as well as elsewhere \[[@pone.0232305.ref031]\]. Two isolates of O84:H2 (ST-306) with LEE and harbouring both *stx*~1~ and *stx*~2a~ genes were also recovered from the Norwegian samples. O84:H2 has been found in cattle and as a cause of sporadic cases of diarrhoea among humans in New Zealand \[[@pone.0232305.ref032]\], but has to our knowledge not been linked to severe cases of illness. However, strains of the same sequence type, ST-306, with different serotypes have been linked to HUS cases in both Germany \[[@pone.0232305.ref004]\] and Sweden \[[@pone.0232305.ref033]\].

Characteristics and public health relevance of LEE-negative STEC isolates {#sec018}
-------------------------------------------------------------------------

LEE-negative STEC are rare, but perhaps underestimated as a cause of HUS, as diagnostics have historically focused on the most well-known LEE-positive serotypes. In general, LEE-negative isolates rely on alternative host tissue adhesion mechanisms, which are either poorly understood or known, but historically associated with other *E*. *coli* pathotypes \[[@pone.0232305.ref009]--[@pone.0232305.ref011]\]. The most notable example of LEE-negative HUSEC is the major outbreak in Europe 2011 of enteroaggregative *E*. *coli* O104:H4 encoding *stx*~2a~ \[[@pone.0232305.ref034]\], but smaller outbreaks and sporadic cases are continuously reported. Two variants of LEE-negative STEC recovered from Swedish cattle in the present study, O113:H21 (ST-223) and O130:H11 (ST-297), have caused sporadic cases of HUS in Sweden \[[@pone.0232305.ref035]\]. O113:H21 (ST-223) is a well-known LEE-negative HUSEC with cases reported from several countries \[[@pone.0232305.ref036]\], while O130:H11 has also been associated with HUS in Australia \[[@pone.0232305.ref037]\] and Argentina \[[@pone.0232305.ref009]\]. The presence of both of these strains in Swedish and Norwegian cattle thus should be considered a public health concern. Another potential HUSEC was an O163:H19, a serotype that has previously been linked to a case of HUS in the UK \[[@pone.0232305.ref038]\]. The remaining serotypes and STs found in the present study have not to our knowledge, been linked to severe illness in humans. However, several known LEE-negative HUSEC could not be distinguished from strains not known to cause HUS in terms of virulence gene repertoire ([Fig 4](#pone.0232305.g004){ref-type="fig"}), this might be due to the selection of genes included in this study which is biased towards LEE-positive STEC and other known pathotypes. Previous studies have had similar difficulties in identifying the virulence determinants of non-LEE HUSEC \[[@pone.0232305.ref039]\], but new potentially relevant markers are continuously being discovered \[[@pone.0232305.ref040]\].

STEC/ETEC hybrid isolates {#sec019}
-------------------------

In recent years, hybrid pathotypes of *E*. *coli* have been reported to be associated with diarrhea and HUS \[[@pone.0232305.ref032],[@pone.0232305.ref039]--[@pone.0232305.ref042]\]. Several isolates obtained in this study carried genes encoding heat-stable enterotoxin 1 (*sta*~1~) in addition to *stx*~2a~ and can thus be considered hybrids between the STEC and ETEC (enterotoxigenic *E*. *coli*) pathotypes. The isolates appear to be related to some extent, belonging to phylogroup A and ST-10, but belonging to multiple serotypes with O2/O50:H27 being the most common. This lineage was found in isolates from both Norway and Sweden, and STEC/ETEC hybrids of matching serotypes have previously been isolated from patients and cattle in Italy and Finland \[[@pone.0232305.ref041],[@pone.0232305.ref043]\]. A single isolate of ST-330 in the present study had both a LEE-region, the ETEC *sta*~*1*~ toxin and belonged to the same clonal complex as the ST-10 STEC/ETEC LEE-negative hybrids. A strain matching the description of the present finding (O101:H33, phylogroup A, ST-330, *sta*~1~+) have been associated with HUS in an infant in Finland in 2001 \[[@pone.0232305.ref044]\]; another isolate with matching phylogroup and ST, but no expressed serotype (ONT:H^-^), has been reported from a German HUS case \[[@pone.0232305.ref004]\].

Conclusions {#sec020}
===========

In this study, we found a substantial proportion of *stx*~*2a*~-positive samples from Swedish and Norwegian cattle. *stx*~2a~ and *stx*~2d~ were the most common variants among Swedish cattle samples analyzed by high throughput amplicon sequencing, however other variants and combinations of variants were also seen. This approach of using amplicon sequencing is a powerful tool for detecting all known *stx*~2~ variants in a sample and reflects the importance of selecting more than one *stx*-positive isolate in a complex sample. Isolation and characterization of 39 *stx*~2a~-positive *E*. *coli* revealed that only a small proportion have similar virulence profiles as known HUSEC-strains and only a few known HUSEC lineages were identified among the *stx*~2a~-positive isolates. We conclude that *stx*~*2a*~-positive *E*. *coli* in cattle are ranging from strains similar to HUSEC to unknown STEC variants. It is currently unclear whether most *stx*~2a~-positive *E*. *coli* pose a risk of causing HUS in a vulnerable patient, or if this capability is an emergent property of combinations of other virulence factors including key adhesins. Due to this unexplored field it would be of interest to compare human and animal isolates further by comparative WGS analysis.

Supporting information {#sec021}
======================

###### Virulence genes in *stx*~2a~ isolates.

(XLSX)

###### 

Click here for additional data file.

The sequencing service for the Norwegian isolates was provided by the Norwegian Sequencing Centre ([www.sequencing.uio.no](http://www.sequencing.uio.no)), a national technology platform hosted by the University of Oslo and supported by the \"Functional Genomics\" and \"Infrastructure\" programs of the Research Council of Norway and the Southeastern Regional Health Authorities.
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L101 Having so much stx appearing in the ear is interesting. A bit more discussion about the use of the ear for sampling would be welcome. We have taken swabs of various parts of bovine anatomy to find STEC, but never considered the ear.
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Line 120- further details of skin sampling required.

Line 137- was any attempt made to confirm that the sensitivity of these assays.

Line 139- why adopt different methods for analysing different samples- explain.
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You have used a ct value of \<45 to indicate a positive sample. Do you know how this relates to cell numbers in this sample, which will contain a mixture of DNA from many different bacterial species present in the sample?

Is there agreement between the levels of stx2a detected by amplicon sequencing and RT-PCR?

Line 168 missing reference -xxxx

Line 199-201 makes me concerned about the sensitivity of this RT-PCR do you have another explanation.

Line 213 It is likely that the low recovery rate relates to the method used as if performed as described in the methods it is likely that many different E. coli and other bacteria will be growing on the plates and identifying the stx positive ones very difficult.

Figure 1a error bars are higher than the axis

Figure 2 can't read poor quality.

Discussion
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Line 289 it's essential to also consider that although stx gene are detected in a sample they may not be associated with E. coli. Consider the presence of free-phage.

Line 320 has any attempt been made to compare the genomes of these isolates if available.
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A copy of the reply to reviewers can be found as a uploaded file, but also pasted in here;

Reply to reviewers

Thank you for comments and suggestions for improving the manuscript. We have tried to answer each comments as good as we can in this response to the reviewers comments.

Reviewer \#1: Well-written and interesting paper, only a few minor concerns

L24 skin samples needs more explanation - as initially guessed rectal biopsy

Answer: We have added (ear) to the description of skin samples in the abstract and explained about the skin samples in the materials and methods (L105-109).

L28 and elsewhere in manuscript - Need to be careful describing isolates as HUSEC. Your cattle isolates might be similar to those which have caused HUSEC, but at present still no absolute way of determining which isolates will cause human disease.

Would instead use \"strains similar to HUSEC\" to make this distinction. If we could perfectly identify HUSEC, would not be a need for your study, but as stated on L 33 we are working towards being able to identify HUSEC (not there yet).

Answer: We totally agree with the reviewer that naming animal isolates as human pathogenic or HUSEC as there is not possible to determine whether they are true human pathogenic or not. We have changed from LEE-positive HUSEC to "LEE-positive strains similar to HUSEC".

L30 ST=sequence type? Needs to be defined

Answer: We have defined ST as sequence type in L30.

L31 same problem as on L28

Answer: We have changed to "Lineages known to include LEE-negative HUSEC were also recovered including, such as O113:H21 (sequence type (ST)-223), O130:H11 (ST-297), and O101:H33 (ST-330)." in L29-L31 and to "strains similar to HUSEC" in L32.

L45 previously associated with HUS

Answer: We have added "previously" to L46.

Table 1 Some interesting nucleotides in these primers. Only familiar with A, C, T, and G. What are Y, W, and R? More description needed here.

Answer: These nucleotides are degenerated bases and represent two binding alternatives and not only one as for A, C, T, G. We have included a description of the degenerate base symbols as a note to Table 1, L92. The codes used are standard as defined by IUPAC.

L101 Having so much stx appearing in the ear is interesting. A bit more discussion about the use of the ear for sampling would be welcome. We have taken swabs of various parts of bovine anatomy to find STEC, but never considered the ear.

Answer: Faecal shedding of STEC seems to be intermittent and often limited to a fraction of the animals in a group. In contrast, skin samples will likely represent an "archive" of recent shedding from the individual animal and other animals in the group. In O157:H7 studies we have found far more positive samples using ears compared to faeces collected in parallel. Therefore, we consider skin samples a cost-effective way of sampling if the goal is to collect as many isolates as possible rather than determining the individual prevalence. Various rubbing, grooming, eating, drinking etc. behaviours are likely to lead to bacteria being transferred to the head of the animal. Compared to other types of skin samples, ears are easy to collect in a standardized manner for the regular slaughterhouse staff. We have expanded the relevant part of the materials and methods section explaining this (L105-L109).

L326 Would suggest deleting \'finding that also represent a\'

Answer: We agree and have deleted this and changed from suspected to "potential HUSEC"

Reviewer \#2: PONE-D-20-09947

The authors describe a study carried out in Sweden and Norway to assess the prevalence of shiga-toxin genes of clinical importance in cattle. While the study is of interest I do not think that in its current form it is not suitable for inclusion in PLOS one without considerable revision.

Introduction -- Good introduction using relevant reference.

Methods -- Authors have used appropriate methods for analysing the sample tested.

Line 120- further details of skin sampling required.

Answer: We have added some details regarding the ear sampling and why this is done. (L105-L109) See also the response to Reviewer 1 above.

Line 137- was any attempt made to confirm that the sensitivity of these assays.

Answer: There was not performed spiking experiments with known number of Stx2-encoding bacteria to confirm the sensitivity of these assays. We are also aware that it might not be accurate enough to estimate limit of detection from the standard curve based on serial dilutions from a positive control, so we suggest to rewrite the following;

L87; "PCR efficiency was assessed by analysing serial dilutions of DNA from the positive control EDL933 in the Swedish lab".

L189-L191; "The PCR efficiency was calculated to be 75% based on the standard curve from serial dilutions of DNA from EDL933."

As we already stated in the discussion, this real-time PCR was primarily used as a screening tool to retrieve stx2a-positive E. coli.

Line 139- why adopt different methods for analysing different samples- explain.

Answer: The method is mainly the same, but we are using different qPCR mastermix. The reason for that is because the two different labs usually prefer the mastermix used and therefore have stocks of this available. We also recognize that we have used different sample volumes which might have an impact on the detection. As this might be of importance for assessing the PCR results. Although we have only tested the method in two laboratories using different PCR reagents and platforms, the results indicate that the method is robust and can easily be used in different laboratories. We have included a paragraph regarding this in the discussion (L290-293).

Results

You have used a ct value of \<45 to indicate a positive sample. Do you know how this relates to cell numbers in this sample, which will contain a mixture of DNA from many different bacterial species present in the sample?

Answer: Since spiking experiments with known levels of stx2a has not been carried out, we do not know how the Ct-value relates to the number of cells in this PCR. We are, however, aware that a Ct-value at 45 might be a false positive. In the case of STEC we consider it more important to avoid false negatives than having a few false positive sample. We have included this in the discussion (L293-296).

Is there agreement between the levels of stx2a detected by amplicon sequencing and RT-PCR?

Answer: Unfortunately, neither method is well suited for quantitative analysis. The real-time PCR is designed to be specific at the cost of sensitivity and has low amplification efficiency. This is due to theoretical constraints from the high sequence similarity of stx2a to other stx2-subtypes. For amplicon sequencing we can exactly count the number of occurrences of each variant in the sample after PCR amplification and library generation, but this amplification is carried out using degenerate primers and is unlikely to have the same efficiency for different stx subtypes. We discussed using digital PCR, but again the low efficiency of the stx2a PCR would likely be a problem, in this case for endpoint signal thresholding.

Line 168 missing reference --xxxx

Answer: The reference in L168 is now added; PRJEB38743.

Line 199-201 makes me concerned about the sensitivity of this RT-PCR do you have another explanation.

Answer: As mentioned above and in the manuscript itself, the sensitivity of the PCR is indeed likely to be suboptimal. This is not a design flaw but a necessary trade-off given the small differences between stx2-subtypes; it was originally designed to verify isolates as stx2a-positive. Here we also use it to screen samples for selecting those with a decent chance of isolating stx2a-positive strains by randomly selecting E. coli colonies. For this purpose specificity is again more important as we are only interested in strongly positive and true positive samples. It is therefore not surprising that the amplicon sequencing assay picks up more positive samples overall in this case, although we do not believe it is more sensitive as a detection technique in general.

Line 213 It is likely that the low recovery rate relates to the method used as if performed as described in the methods it is likely that many different E. coli and other bacteria will be growing on the plates and identifying the stx positive ones very difficult.

Answer: The low recovery rate could definitively be due to high E. coli diversity and mainly other E. coli growing on the plates and therefore very difficult to identify the stx2a-positive bacteria. Another alternative might be colony hybridization with a specific probe, however, due to background noise this might not be a better option. Colony hybridization might require a copy of the plates for later selecting the stx positive colonies and would probably be more time consuming.

Figure 1a error bars are higher than the axis

Answer: The first author has access to the original figure 1a and are unfortunately on vacation at the moment. However, as soon as he is back we will upload a corrected Figure 1a. Hope that is acceptable for editor and the reviewer.

Figure 2 can't read poor quality.

Answer: To the authors' knowledge the quality of figure 2 is of sufficient quality when downloading the figure separately. The figure have been uploaded to PACE (<https://pacev2.apexcovantage.com/>) before submission to ensure that the figure meets PLOS One requirement. However, we have uploaded the original figure 2 which is in a wrong file format to see if that could help regarding the quality.

Discussion

Line 269 remove either

Answer: We have removed "either".

Line 279 Please explain why sensitivity is not important?

Answer: We have added a sentence further explaining why sensitivity could not be prioritized (L288-290).

Line 289 it's essential to also consider that although stx gene are detected in a sample they may not be associated with E. coli. Consider the presence of free-phage.

Answer: This is mentioned in the first paragraph of the discussion as a possible reason for PCR-positive samples. However, free phages are likely more of a concern in studies where samples are directly analysed by PCR, in the present study all samples are pre-enriched amplifying prophage stx genes.

Line 320 has any attempt been made to compare the genomes of these isolates if available.

Answer: Unfortunately we do not have access to genome data from the human isolates.

Line 330 consider using other databases to identify virulence determinants if the one used is bias towards LEE. Did you search you genomes for genes discussed in ref. 41?

Answer: To the authors' knowledge virulence databases are difficult to interpret as many genes are virulence-associated or fitness genes, but not enough to cause disease alone. The people curating such databases need to have in depth knowledge about virulence genes and to our knowledge we are not aware of any virulence databases covering these new potential virulence-associated genes. We did not test specific virulence-associated genes as those referred to in ref. 41.

Line 350 how do you determine significance.

Answer: "Significant" in a colloquial sense; we have now replaced the word with "substantial".
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